Latest Articlesddd
Rhythm Pharmaceuticals in the NEWS Rhythm Pharmaceuticals, Inc. (RYTM) announced that the U.S. FDA has accepted …
Precigen in the NEWS Precigen (PGEN) announced that the United States (FDA) has approved the product PAPZIMEOS™ (zopapogene imadenovec-drba) …
Insmed Incorporated Today, investors must have realized the upward movement prices of the Viking Therapeutics (VKTX) …
Boehringer Ingelheim The following is not for investors but for people who love pets and want …
Akero Therapeutics Akero Therapeutics (AKRO) reported its Q22025 financial results for the period ending June 30, …
Gilead Sciences Reached Prohost Biotech's Target Gilead Sciences (GILD) reached our target of $120 today. Some …
Praxis Precision Medicines in the NEWS On Aug. 04, 2025, the biopharmaceutical company Praxis Precision Medicines …
Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress The Financial Results …
AstraZeneca Imfinzi Based on MATTERHORN Phase III trial results which demonstrated a statistically significant and clinically …
Klotho Neurosciences to Pursue Technologies to Improve Brain Function, Muscle Strength, Bone Health, and Other Longevity …
GSK in the NEWS Today, GSK plc (GSK) announced the launch of the Linked by Lupus: …
Eli Lilly Acquired Verve Therapeutics Eli Lilly and Company (LLY) today announced the successful completion of …
AstraZeneca's Product Gefurulimab Once-weekly self-administered subcutaneous C5 inhibitor showed statistically significant and clinically meaningful reduction in …
AstraZeneca in the NEWS Cornerstone of investment is a proposed new multi-billion dollar drug substance manufacturing …
Axsome Therapeutics Axsome Therapeutics (AXSM) is a biopharmaceutical company leading a new era in the treatment …
Friday, August 18, 2025 Solid Earning, revenue growth, President Trump signing crypto bills, and Crispr Therapeutics …
Q & A: Kiniksa Pharmaceuticals Q: Do you have any recent news from Kiniksa Pharmaceuticals? A: …
The root-cause of the stock market’s volatility and inflation does not make sense as we are …
Vertex Pharmaceuticals in the NEWS On Jul. 1, 2025, Vertex Pharmaceuticals (VRTX) announced that the European …
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer We wanted to know the …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
